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Abstract
Background: Propofol is administered as intermittent boluses to achieve deep sedation to facilitate oesophagogastroduodenos-
copy. Target controlled infusion (TCI) can be employed for this purpose.
Methods:  176 adults were randomly allocated into two groups of  88 patients. Control group: Received an initial bolus of  
propofol 1mg/kg, with repeat boluses of     0.25mg/kg. Intervention group: Received an initial target effect-site concentration of  
4mcg/ml, followed by maintenance target effect-site concentration of  2.5mcg/ml, titrated by 0.5mcg/ml from baseline infusion 
rate as needed. Oxygen saturation, blood pressure and heart rate were evaluated immediately before administering the sedative 
and at 2.50, 5.00, 7.50 and 10.00 minutes. Oxygen desaturation below 90% in both study groups was recorded. Sedation starting 
time, stopping time, waking up time and overall duration of  time to recovery of  participants in each study arm was recorded. 
Results: More hypoxic episodes were observed in the intermittent bolus group with statistically significant association between 
control and the incidence of  hypoxia: Chi square test, p=0.037. There were more hypotensive episodes in the TCI group  but 
not achieving statistical significance: Chi square test for association X2(1) = 0.962, p=0.327.The time to recovery between the 
two groups was comparable, with 18.84 ± 10.76 minutes in the bolus group and 19.72 ± 9.27 minutes in the TCI group; no 
statistically significant difference was shown: Student’s t-test, p=0.0564.
Conclusion: TCI of  propofol   was associated with fewer episodes of  hypoxia compared to intermittent bolus administration. 
Similar hemodynamic profiles and comparable time to recovery were demonstrated by these two sedation techniques.
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Introduction
In recent years, there has been a notable increase in the 
number of  patients requiring upper and lower gastro-
intestinal endoscopic studies as an essential part of  the 
diagnostic and treatment strategy for gastrointestinal 
pathologies1-2. The increased training and availability of  
specialists performing these procedures has contributed 
to the steady rise in the numbers of  endoscopy proce-
dures done, as has the need for provision of  procedural 
sedation for this invasive procedure3. Sedation has been 
shown to be essential for gastrointestinal endoscopy to 
be carried out successfully4,5.
The American Society of  Anesthesiologists classifies se-
dation as minimal, moderate and deep depending on the 
patient’s responsiveness, ability to sustain an airway that 
is patent, spontaneous ventilation and a reasonably sus-
tained cardiovascular stability6.
At present, propofol is the intravenous sedative agent 
possessing properties closest to that of  an ideal sedative 
owing to its fast onset and ultra-short duration of  action; 
it is no wonder then how rapidly it has gained popularity 
as the preferred sedative for short procedures. Moreover, 
its favorable pharmacokinetic and pharmacodynamic 
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profile gives it the unique ability to provide varying levels 
of  sedation7. As such, propofol has secured a favorable 
position in procedural sedation as has been elaborated 
in guidelines published by the American Society of  An-
esthesiology (ASA) for the safe conduct of  sedation for 
various diagnostic and therapeutic procedures including 
gastrointestinal endoscopy8. However, propofol is an 
anaesthetic agent with a narrow therapeutic range, and 
without a reversal agent. The clinical implication of  this 
is that propofol has a low threshold for inducing a deep-
er level of  sedation than intended, compounded by an 
increased risk of  hypoventilation, apnoea or cardiovas-
cular depression. Hence, it is largely recommended that 
anaesthesiologists or nurse anaesthetists administer this 
sedative agent.
For the conduct of  procedural sedation, propofol may 
be administered as intermittent boluses or via continu-
ous infusion; the latter technique requiring the use of  a 
drug infusion pump that requires one to either manually 
adjust the rate of  infusion or, use a target controlled infu-
sion system – which allows more accurate rapid titration 
of  the dose of  this agent. A target sedation state refers 
to a pharmacologically induced alteration in the level of  
consciousness that allows a subject to tolerate unpleasant 
procedures while aiming to maintain cardiovascular and 
respiratory stability9.
The present study set out to compare the overall pro-
portion of  hypoxia between patients undergoing upper 
gastrointestinal endoscopy under sedation by intermit-
tent intravenous bolus administration of  propofol – the 
standard practice at the Aga Khan University Hospital 
Nairobi – and target controlled infusion (TCI) of  the 
same sedative agent. Target controlled infusions are com-
puterized infusion systems based on pharmacokinetics 
and pharmacodynamic models specified for the individu-
al by entering variables such as age, gender and weight10. 
From these, a mathematical model can be designed and 
applied in predicting the plasma concentration profile of  
a given pharmacological agent after a bolus dose is giv-
en, or following an infusion of  the drug. These models 
are deduced from the measurement of  arterial or venous 
plasma concentration of  the drug using standardized sta-
tistical methods and models of  computer software that 
are incorporated in the infusion pump11.
Numerous algorithms for targeting blood and effect site 
concentration have been published and several automated 
systems have been developed. Examples of  TCI models 
available for the use of  Propofol are Marsh and Schnider 
models11.
With target-controlled infusion, a steady-state level 
of  propofol sedation can be attained by attempting to 
achieve a user-preset target blood drug concentration12, 
with a provision for rapid titration in response to varying 
degrees of  procedural stimulation. It therefore confers to 
the user a high level of  confidence regarding the predict-
ability of  depth of  sedation.
In theory therefore, a more consistent level of  sedation 
can be achieved by this technique, minimizing the highs 
and lows of  plasma levels of  propofol, which are experi-
enced when, repeated boluses of  are administered13. In so 
doing, the degree of  hypotension encountered would be 
reduced, as would the intensity of  respiratory depression, 
which can lead to apnoea and hypoxaemia. Additionally, 
TCI may also be associated with a reduce need for inter-
ventions by the person administering the sedative; thus, 
effectively “frees” the anesthetist’s hand and allows for 
better direct monitoring of  the patient. Endoscopic se-
dation presents the unique challenge of  “sharing the air-
way” with the gastroenterologist, rendering it persistently 
at risk as the airway is not protected. Foremost in the pru-
dent anesthesiologist’s safe sedation strategy is to choose 
a regime that is associated with fewer incidences of  re-
spiratory depression that can lead to oxygen desaturation 
and hypoxia.
The aim of  this study was to compare the proportion of  
hypoxia between targets controlled infusion and intermit-
tent bolus administration of  propofol in adult patients 
undergoing sedation for upper gastrointestinal endosco-
py. Our study question was: is there a difference in the 
proportion of  hypoxia between targets controlled infu-
sion and intermittent bolus administration of  propofol in 
adult patients undergoing sedation for upper gastrointes-
tinal endoscopy?
We hypothesized that there is no difference in the pro-
portion of  hypoxia between target controlled infusion 
and intermittent bolus administration of  propofol in 
adults undergoing sedation for upper gastrointestinal en-
doscopy.
Methods
The study was performed following approval from the 
ethical and scientific review committee at the Aga Khan 
University Hospital, Nairobi.  This was an open-label 
randomized controlled trial. The study was carried out 
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at the Aga Khan University Hospital, Nairobi, a tertiary 
facility with a bed capacity of  280; a facility that is home 
to a host of  postgraduate medical education programs. 
Patients seeking care from this not-for-profit facility are 
drawn from diverse geographical backgrounds. The pa-
tients who took part in this study were enrolled from the 
preanaesthesia clinic, the inpatient wards and the endos-
copy department. A participant flow diagram is shown in 
figure 1.
The target population included all adults scheduled for 
non-emergent diagnostic or therapeutic upper gastroin-
testinal endoscopy i.e. oesophagogastroduodenoscopy 
(OGD) under sedation. The sample population included 
ASA I and II adults between the ages of  18 - 65 years 
who were to undergo non-emergent upper gastrointesti-
nal endoscopy at the Aga Khan University  between Jan-
uary 2017 and March 2017 under sedation. Reasons for 
exclusion from the study were:
1. Known allergy to propofol, midazolam, soybean, egg.
2. Active respiratory infection.
3. History or indicator of  large airway compromise e.g. 
obstructive sleep apnoea, chronic obstructive pulmonary 
disease, presence of  stridor, or known history of  difficult 
bag-valve-mask ventilation.
4. Patients requiring additional types of  sedative agents to 
achieve optimal sedation.
5. History of  chronic exposure to sedative medication. 
 
The present study applied a margin of  0.12; a difference 
of  8% was considered to be significant should there be 
a difference in the proportion of  hypoxia observed be-
tween the two modes of  administering propofol during 
the conduct of  OGD. The sample size for the study was 
determined using the non-inferiority formula. This sam-
ple was sufficient for the test of  non-inferiority or equiva-
lence between target controlled infusion and intermittent 
bolus administration of  propofol in the proportion of  
patients that develop hypoxia. In applying the above for-
mula, with the assumption of  a significance level of  5%, 
and a power of  80%, a sample size of  80 patients per arm 
was deemed adequate to demonstrate an 8% difference in 
the proportion of  hypoxia between patients in these two 
groups. Upon accounting for up to a 10% drop-out rate, 
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a total sample size of  176 (88 in each arm) was arrived at.
Patients scheduled for gastrointestinal endoscopy were 
screened and assessed for eligibility during the pre-anaes-
thesia assessment visit in the anaesthesia clinic, in-patient 
ward reviews and the endoscopy department. The use of  
consecutive sampling was applied, meaning: there was op-
portunity to recruite every subject who was found to be 
eligible to participate in this study. An informed consent 
was obtained from the patient by the primary investigator 
after an elaborate description of  the purpose and nature 
of  the study had been provided. Ample time was also 
allocated to satisfactorily address any questions that they 
may have had. Participants from whom informed consent 
had been obtained were assigned randomly to either arm. 
A total of  88 yellow cards and 88 blue cards were put 
in brown (opaque) envelopes and sealed at the start of  
the study. These envelopes were then mixed well togeth-
er; each colored card representing one arm of  the study. 
Yellow cards represented the intervention arm (target 
controlled infusion) and the blue cards represented the 
control arm (intermittent bolus). Once the participants 
provided consent to participate in the study, they were re-
quired to take any envelop and open it to display the card 
it contained. The revealed card was then placed in the 
participant’s file for ease of  identification of  the group 
they had been randomized into and to guide the adminis-
tration of  the appropriate mode of  intravenous propofol 
for sedation as described for the respective arms.
Upon arrival at the endoscopy suite, the anaesthetist ad-
ministering sedation opened the patient’s file and saw 
from the colour of  the card contained therein which arm 
the patient had been randomized into. Standard moni-
toring was commenced: electrocardiography, automated 
non-invasive blood pressure measurement and pulse ox-
imetry. Supplemental oxygen via nasal prongs at 3 liters 
per minute was given to all patients in both study arms 
at least 3 minutes before commencing sedation. Intrave-
nous midazolam 0.05mg/kg was administered to subjects 
in both study arms. In the intermittent bolus group: An 
initial bolus propofol 1mg/kg, followed by repeat boluses 
of  0.25mg/kg as needed was given till the end of  the pro-
cedure. In the target controlled infusion group: Effector 
targeted Schneider model was used via target controlled 
infusion pump model, Injectomat TIVA agilioTM.  Initial 
target effect-site concentration of  4mcg/ml for propo-
fol was given until loss of  consciousness was achieved. 
This was immediately followed by a target effect-site con-
centration infusion of  2.5mcg/ml, titrated by 0.5mcg/
ml upward or downward as needed till the end of  the 
procedure. A Ramsay sedation score of  <5 was used as 
criteria for additional dosing14. We opted to use the Ram-
say Sedation Scale because it is the scoring system most 
commonly referred to at our facility.
Patients were monitored continuously; non-invasive 
blood pressure measurements were time-cycled to take 
automated readings at 2.5-minute intervals. The heart 
rate, respiratory rate and oxygen saturation was depicted 
by continuous respective waveforms and corresponding 
numerical values on the monitor screen throughout the 
procedure.
Upper gastrointestinal endoscopy was started by gastro-
enterologist only after patient entered deep sedation. Any 
episode of  oxygen desaturation below 90% was docu-
mented; airway maneuvers such as chin-lift and jaw-thrust 
were applied promptly to re-establish patency of  airway. 
If  the patient became apnoeic, the endoscopy procedure 
was to be interrupted and mask ventilation with high-
flow 100% oxygen was to be administered until there was 
resumption of  spontaneous ventilation. The end of  the 
endoscopy sedation procedure was marked by withdrawal 
of  the endoscope from the mouth. The patient was then 
transferred to the post-sedation recovery room for con-
tinuous monitoring till point of  being discharged from 
the endoscopy suite to go home or to the ward. The time 
to recovery from sedation was recorded for each patient 
in both study arms i.e. duration of  time from the end of  
the endoscopy procedure signaled by withdrawal of  the 
scope from the oral cavity and cessation of  administra-
tion of  the sedative, to the time to respond to a verbal 
command. This was assessed at 5-minute intervals. The 
verbal command was given by the recovery room nurse 
who stood by the patient’s bed on the side he or she was 
facing, and called them by their name no more than twice 
at a time, in a normal/conversational tone. The patient 
was neither touched nor subjected to any other form 
of  stimulation in an attempt to determine their level of  
wakefulness. This routine was also well described to the 
recovery room nurses as well as practically demonstrated 
to them how to correctly make this assessment. In addi-
tion, I frequently went to the recovery room to ensure 
this was uniformly adhered to.   
 
Data was checked for accuracy and completeness, then 
entered and analyzed by use of  SPSS (Version 21.0, Chi-
cago-Illinois). Continuous data was analyzed and summa-
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 Table 1: Comparison of Baseline Characteristics between Bolus and TCI Groups 
  
  Frequency n (%) p-value 
BOLUS TCI 
  Mean(±SD) Mean(±SD)     
Age 38.6(13.2) 39.0(11.3) 0.502 
Sex       
Male 39 (44.3) 43 (48.9) 0.546 
Female 49 (55.7) 45 (51.5) 
ASA classification       
I 53 (60.2) 66 (75.0) 0.036 
II 35 (39.8) 22 (25.0) 
        
Mean Weight 71.3( 12.3) 74.1(14.62) 0.388 
Mean Height 167.4(7.1) 169.3(6.57) 0.054 
Mean BMI   25.5 (3.7) 
  
25.6 (4.29) 
0.655 
Mean Initial blood pressure 
(mmHg) 
Mean ± SD   
  Bolus TCI   
Systolic 123.7 (19.1) 120.3 (18.9) 0.226 
Diastolic 75.8 (14.7) 72.5 (10.6) 0.082 
Mean HR 83.2 (13.9) 85.2 (13.4) 0.338 
Mean SpO2 95.57 (1.7) 96.8 (1.8) 0.304 
  
rized as means and standard deviation while the categori-
cal data was analyzed and displayed by use of  frequencies 
and proportions. The proportion of  patients with hypox-
ia (primary outcome) between the TCI and intermittent 
bolus groups was compared with the use of  Chi-square 
test. The secondary outcome (hypotension and time to 
recovery in minutes) was compared with the use of  in-
dependent sample t-tests. Where applicable, P-values and 
95% confidence intervals (CIs) were also to be calculated. 
A P value <0.05 was considered statistically significant, 
based on two-sided tests.
Results
The age, sex, weight, and height were not significantly 
different (p=0.502; p=0.546; p=0.388; p=0.054) in both 
groups as shown in table 1. The TCI group had a systolic 
blood pressure of  120.25 ± 18.87, while that of  the Bolus 
group was 123.73 ± 19.13; a difference of  3.48mmHg that 
was not statistically significant (95% CI, -2.18 to 9.13), t 
(174) = 1.214, p = 0.226. However the bolus group had a 
baseline diastolic blood pressure of  75.84 ± 14.73, while 
that of  the TCI group was 72.45 ± 10.63; a difference 
of  3.39mmHg which also was not statistically significant 
(95% CI, -0.44 to 7.21), t (174) = 1.749, p =0 .082.
The bolus group had more cases of  hypoxia (n = 28) than 
the TCI group (n = 16).This was statistically significant, p 
= 0.037 (95% CI, 1.039 to 4.243).This is shown in table 2.
The bolus and TCI groups were assessed for occurrence 
of  hypotension. As earlier defined in this study, hypo-
tension was described as a 20% decrease in the baseline 
systolic blood pressure. 
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Table 3: Proportion of Hypotension between Bolus and TCI Groups 
  
Group Frequency n (%) p-value 
Yes 
 
No 
Bolus 24 (27.3) 64 (72.7) 0.327 
TCI 30 (34.1) 58 (65.9) 
  
  
It was found that of  those in the TCI group, 30 (34.1%) 
had experienced hypotension compared to 24 (27.3%) 
of  the Bolus group. This finding was not statistically sig-
nificant, p=0.327 (95% CI, .381 to 1.380).This shown in 
table 3. 
Table 4: Comparison of Heart Rate between Bolus and TCI Group 
 
  Bolus TCI p-value 
Heart rate (Mean ± SD) - Initial 83.17± 13.94 85.15± 13.35 0.338 
An independent-samples t-test carried out to determine if there were differences in the heart rate in patients receiving  
Bolus and TCI for sedation. 
  
The Bolus arm had a mean heart rate of  83.17± 13.94 
compared to the TCI arm (85.15± 13.35), a difference of  
2.06 (95% CI, -6.04 to 2.08), t (174) = 1.214, p = 0.338. 
This is shown in table 4.
 Table 5: Comparison of Duration of Sedation between bolus and TCI groups 
 
  Mean ± SD p-value 
Bolus TCI 
Duration of Sedation (in minutes) 6 ± 3 6 ± 1 0.519 
An independent-samples t-test run to determine if there were differences in the duration of sedation in patients receiving  
Propofol boluses versus TCI during sedation. 
It was found that participants in the Bolus group had 
a comparable duration of  sedation to those in the TCI 
group (6 ± 3 and 6 ± 1 minute, respectively). Not only 
was the duration of  sedation not statistically different, 
but the difference was also clinically insignificant. (95% 
CI, -0:00 to 0:01), t (174) = 1.214, p = 0.519. This shown 
in table 5.
Table 2: Proportion of Hypoxia between Bolus and TCI Groups 
  
Group Frequency n (%) p-value 
Yes No 
Bolus 28 (31.8) 60 (68.2) 0.037 
TCI 16 (18.2) 72 (81.8) 
An independent-samples t-test applied to determine if there  
were differences in the initial systolic blood pressure in patients  
receiving Bolus and TCI for sedation. 
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Table 6: Comparison of Recovery Time between Bolus and TCI Groups 
 
  Bolus TCI p-value 
Recovery time in min (Mean ± SD) 18.84±10.77 19.72±9.28 0.564 
Range (min) 5 - 66 3 - 42   
An independent-samples t-test run to determine if there were differences in the recovery times in patients receiving Bolus and  
TCI for sedation. 
  
Table 7: Distribution of Patients by Duration Taken to Wake Up 
  
Duration (minutes) 
Frequency n (%) p-value 
Bolus TCI 
≤ 5 2 (2.3) 5 (5.7) 0.198 
6 – 10 18 (20.5) 6 (6.8) 
11 – 15 24 (27.3) 25 (28.4) 
16 – 20 13 (14.8) 14 (15.9) 
21 – 25 13 (14.8) 13 (14.8) 
26 – 30 7 (8.0) 11 (12.5) 
>30 11 (12.5) 14 (15.9) 
Total 88 (100.0) 88 (100.0) 
A C 
The Bolus group had a shorter recovery time (18.84 ± 
10.77) compared to the TCI group (19.72 ± 9.28); a dif-
ference that was not statistically significant (95% CI, -2.12 
to 3.87), t (174) = 0.578, p = 0.564. This is shown in table 
6. No statistically significant association between inter-
vention and duration taken to wake up was demonstrated, 
χ26) = 8.592, p = 0.198.This is shown in table 7. Of  the 
patients who took longer than 30 minutes to wake up in 
either group, the majority of  them woke up between 31 
and 40 minutes. The longest time asleep in the TCI group 
was 42 minutes, and 48 minutes in the Bolus group.
Discussion
The conduct of  gastrointestinal endoscopy has in recent 
years seen an appreciable rise in the numbers of  diagnos-
tic and therapeutic procedures being carried out. This is 
perhaps driven by an increasing awareness by the lay pub-
lic of  the benefits of  undergoing this investigation giv-
en the apparent rise in the incidence of  gastrointestinal 
pathologies – including cancers, alongside the increasing 
training opportunities and growing availability of  gas-
troendoscopy specialists. With this comes the inevitable 
need to avail procedural sedation to facilitate the conduct 
of  these invasive investigations. Manual intermittent bo-
lus administration of  propofol has been the main-stay 
mode of  providing a Propofol-based sedation regimen. 
However, in the recent years, target controlled infusion 
of  propofol for procedural sedation has steadily gained 
popularity.
The present study set out to investigate and compare 
the proportion of  hypoxia between adults receiving in-
termittent boluses of  propofol versus target controlled 
infusion of  propofol for sedation during upper gastroin-
testinal endoscopy. In addition, the study was also guid-
ed by the following secondary objectives: to compare the 
proportion of  hypotension and bradycardia between the 
two study arms, as well as the time to recovery between 
the two groups.
The key finding was that the occurrence of  hypoxia was 
proportionally higher in the intermittent bolus group 
(31%) compared to that in the TCI group (18%) - a find-
ing that was deemed statistically significant p = 0.037. Yi-
Ting Chang et al found a similar observation in a study 
involving 100 subjects, where he explored the quality and 
plausibility of  propofol TCI as a sedation method for en-
doscopy15. Although it was reported that there was no 
statistically significant difference in the overall respiratory 
effects observed between the two arms, the actual num-
ber of  patients who experienced oxygen desaturation re-
quiring intervention was higher in the control group. In 
both instances, respiratory depression and hypoxia was 
observed soon after administering the induction dose of  
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propofol. This may be attributed to the sudden surge in 
the plasma and target site concentration of  propofol that 
is characteristic of  bolus administration of  a relatively 
large dose of  the drug within a short period. While this 
may well confer the advantage of  rapid loss of  conscious-
ness and achievement of  the desired depth of  sedation, 
the respiratory-depressant effect of  propofol is accentu-
ated leading to bradypnoea, hypopnea or apnoea, and ox-
ygen desaturation. In a study similar to the present one, 
Arif  H M Marsaban et al compared sedation outcomes 
between these two sedation techniques, including the to-
tal consumption of  propofol, side effects and recovery 
time4. Here too, the incidence of  desaturation was found 
to be proportionally larger in the bolus group (12%) than 
in the intervention group (4%). However, the variable 
power of  the study was very low and so the accuracy of  
the conclusions of  this particular study could not be as-
certained.
Concerning haemodynamic parameters, the proportion 
of  hypotension was found to be proportionally higher in 
the intervention group, with 34% of  subjects in the TCI 
arm recording systolic blood pressures below 20% of  
the baseline value, compared to 27% in the bolus group. 
However, a statistically significant association between 
intervention and hypotension was not demonstrated. 
In a clinical trial involving 100 participants undergoing 
OGD and 120 scheduled for colonoscopy Chan WH et 
al12 found that, of  the subjects undergoing OGD, signifi-
cantly lower trough systolic blood pressures were doc-
umented in the control group (105 +/- 19mmHg) ver-
sus TCI group (113 +/- 20mmHg) p=0.043. However, 
this study did not report analysis of  the variation of  the 
systolic blood pressure from the baseline. This may have 
been significant. Important to note, too, is that the partic-
ipants in that study had been randomly enrolled to receive 
TCI with propofol or intermittent boluses of  a cocktail 
regimen containing propofol, midazolam and alfentanil. 
The latter two drugs (a benzodiazepine and an opioid) 
are pharmacological agents with cardiovascular depres-
sant effects in their own right; the drop in blood pressure 
that was experienced by these patients was probably be-
cause of  the combination of  the peripheral vasodilalatory 
effect of  propofol and the direct cardio-depressant ef-
fects of  alfentanil. Repeated bolus administration of  this 
sedative cocktail would likely – and predictably – render 
a cumulative cardiovascular depressant effect, leading to 
higher rate of  hypotension in the patients receiving bo-
luses of  the cocktail regimen than those in the TCI group 
who received an infusion of  propofol alone. This may 
have influenced the findings of  the study in this regard. 
By not including the use of  an opioid agent in only one 
arm of  the sedation protocol, the present study obviated 
the confounding influence of  an opioid on the overall 
haemodynamic profile of  the patients, thereby arriving at 
a more accurate conclusion of  the effect of  either seda-
tion techniques on the haemodynamic parameters of  the 
patients.
It is prudent now to acknowledge that, in the current 
study as well as in the referenced trials, the pre-proce-
dure fluid status of  the participants was not known; we 
therefore cannot rule out the possibility of  some of  them 
being relatively fluid-depleted at the start of  administra-
tion of  the sedation regien. As such, the association of  
either mode of  propofol administration (TCI or intermit-
tent boluses) to the occurrence of  hypotension may have 
been exaggerated.
In the present study, one patient experienced a transient, 
self-limiting episode of  bradycardia (defined by a heart 
rate below 50 beats per minute) whose lowest heart rate 
recorded was 47 beats per minute. This subject was in the 
bolus group; of  note is that this participant had a relatively 
low initial heart rate of  61 beats per minute (compared to 
the mean baseline heart rates of  83.17 ± 13.94 and 85.15 
± 13.35 – in the control and TCI groups, respectively) 
that may have predisposed the patient to developing an 
even slower heart rate soon after receiving the induction 
dose of  Propofol. This event was not clinically signifi-
cant as it lasted less than 30 seconds, with resumption of  
normal heart rate without requiring any pharmacological 
intervention to treat it. The patient’s blood pressure was 
not adversely affected and remained stable throughout 
the rest of  the course of  the procedure.
Upon analysis of  the recovery time between the two 
groups, it was noted that of  those who responded to a 
verbal command within 5 minutes of  cessation of  the 
sedation regimen, most had been recipients of  a target 
controlled infusion of  Propofol; perhaps a representa-
tion of  the patients whose procedure time was relatively 
shorter than the rest and therefore had an overall lower 
consumption of  Propofol, predictably leading to a faster 
recovery time. With the exception of  the cluster of  pa-
tients in the Bolus group who woke up 6 – 10 minutes 
that formed the majority in that time cluster, the overall 
time to recovery between the two propofol sedation tech-
niques was largely found to be comparable; with no sig-
nificant difference demonstrated in the bolus (M=18.84, 
SD=10.767) and TCI (M=19.72, SD=9.276) arms, t (174) 
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= .578, p=.564, suggesting that the time to recovery was 
not affected by the method used for sedation.
In revisiting the study protocol, specific interventions 
were to be administered promptly in case any serious re-
spiratory or cardiovascular complications occurred. With 
the exception of  one patient in the TCI group who devel-
oped moderately severe laryngospasms at the end of  the 
procedure, no other serious complication was observed 
in any of  the other study participants. A single or com-
bination of  factors may trigger laryngospasm in a patient 
undergoing an invasive diagnostic or therapeutic inter-
vention. In an analysis of  incidences reported to the Aus-
tralian Incident Monitoring Study (AIMS) that involved 
voluntary reporting of  any unintended incident that oc-
curred in the course of  care of  a patient, of  the first 4000 
reports, 189 were cases of  laryngospasm.  Amongst the 
precipitating factors attributed are airway manipulation 
(44%), blood/secretions in the pharynx (12%), regur-
gitation/vomiting (9%), surgical stimulus (5%), moving 
patient (4%), irritant volatile agent (2%) and failure of  
anaesthetic delivery system (2%). In 22% of  patients who 
experienced laryngospasm no clear cause could be iden-
tified16. Propofol in itself  has a suppressive effect on the 
airway reflexes; compared to volatile anesthetic, the use 
of  propofol sedation/anesthesia is associated with re-
duced airway hyperreactivity12, and is in fact the agent of  
choice in the management of  laryngospasm by increasing 
the depth of  anaesthesia, with or without paralysis with 
succinylcholine18. It is therefore improbable that target 
controlled infusion of  this agent was a precipitating fac-
tor of  laryngospasms in that single subject in the TCI 
group. Instead, it more likely would have been attributed 
to the production of  excessive airway secretions during 
the conduct of  OGD, an observation that was peculiar 
to this patient, and perhaps the stimulation of  the oro-
pharynx with the endoscope in a moment of  a lighter 
plane of  sedation than was intended. This complication 
was expeditiously managed by oropharyngeal suction-
ing of  secretions and administering continuous positive 
pressure ventilation of  100% Oxygen via a Mapleson A 
circuit, with resolution of  the airway spasms soon after. 
The patient went on to recover from sedation without 
any further untoward events.
By demonstrating a lower proportion of  hypoxia with 
the use of  target controlled infusion compared to inter-
mittent bolus administration of  Propofol, the results of  
this study therefore rejects the null hypothesis: there is no 
difference in the proportion of  hypoxia between targets 
controlled infusion of  propofol and intermittent bolus 
administration in adults undergoing sedation for upper 
gastrointestinal endoscopy.
Strengths
This study is the first of  its kind to be conducted in a 
tertiary facility in this region of  the globe.
Limitations
As this was a single-centre trial conducted at a tertia-
ry facility, the results obtained in this study may not be 
generalizable across different clinical set-ups and patient 
populations. Secondly, neither the anaesthesiologist nor 
the endoscopist was blinded in this study, resulting in a 
Hawthorne effect, which may have invariably influenced 
the sedation outcomes under study. However, the na-
ture of  the study in itself  rendered blinding of  the an-
aesthesiologist and endoscopist impossible. Thirdly, the 
induction and maintenance doses of  Propofol in either 
arm of  the study were empirically determined; at best, 
these were closely related to the doses used in comparable 
studies12,16,17. Even then, for both propofol sedation tech-
niques the sedative was given by titrating it to effect, with 
the goal of  achieving a Ramsay score of  5.
 
Conclusion
In conclusion, based on the findings of  this study, tar-
get controlled infusion of  propofol at a targeted effec-
tor site concentration of  2.5mcg/ml is associated with a 
lower proportion of  hypoxia compared to intermittent 
bolus administration of  Propofol at 0.25mg/kg given as 
required. In this regard, TCI mode of  propofol sedation 
has been demonstrated to provide a safer alternative to 
the traditional manual intermittent bolus administration 
of  the same sedative agent. The single episode of  laryn-
gospasms observed in one patient in the TCI group may 
have been attributed to the presence of  copious airway 
secretions rather than the mode of  propofol sedation giv-
en. Additionally, the results of  this study suggest that the 
haemodynamic profile as well as the time to recovery is 
not influenced by the choice of  propofol sedation tech-
nique used.
Trial registration PACTR201708002325400 
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